Quick Answer
Dare Bioscience, Inc. reported Operating Income of -$13.55 million for fiscal year 2025.
Dare Bioscience, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$13.55M | +42.2% |
| 2024 | -$23.45M | +24.2% |
| 2023 | -$30.94M | +1.4% |
| 2022 | -$31.39M | +19.7% |
| 2021 | -$39.07M | -42.6% |
| 2020 | -$27.40M | -91.0% |
| 2019 | -$14.34M | +15.0% |
| 2018 | -$16.88M | -51.0% |
| 2017 | -$11.18M | -1673.0% |
| 2016 | -$630.6K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.67M | +21.6% | +4.1% |
| June 30, 2025 | -$3.83M | +48.0% | +16.4% |
| March 31, 2025 | -$4.58M | +23.9% | +2.1% |
| September 30, 2024 | -$4.68M | +44.2% | +36.4% |
| June 30, 2024 | -$7.36M | +18.1% | -22.2% |
| March 31, 2024 | -$6.02M | +28.2% | +28.3% |
| September 30, 2023 | -$8.40M | -17.6% | +6.6% |
| June 30, 2023 | -$8.99M | -2439.0% | -7.2% |
- Dare Bioscience, Inc. showed an increase of +42.2% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Dare Bioscience, Inc.’s operating income has declined by 2049.1% (from -$630.6 thousand to -$13.55 million).
- The most recent figure is from Dare Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: